Objective: To highlight the current knowledge of the efficacy of dextrose as a prolotherapy agent in managing temporomandibular joint internal derangement (TMJ-ID).

Methods: A "Population, Intervention, Comparison, Outcome" (PICO) strategy was executed using an electronic search through PubMed/MEDLINE, Cochrane databases, and Google Scholar from their inception to August 2022. Only randomized clinical trials investigating the treatment of TMJ-ID with hypertonic dextrose prolotherapy (HDPT) were included. Two independent reviewers assessed the eligibility of the studies with subsequent data extraction.

Results: The systematic search identified 392 studies, and only 8 articles were considered eligible for selection, with a total of 286 patients; 72% were females, and 28% were males. The extracted data showed positive effects of dextrose on joint pain and maximum mouth opening (MMO) with high patient satisfaction.

Conclusion: HDPT can be effective in relieving TMD symptoms as it reduces pain, improves joint dysfunction, and increases MMO up to 12 months.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08869634.2023.2204042DOI Listing

Publication Analysis

Top Keywords

dextrose prolotherapy
12
temporomandibular joint
8
joint internal
8
dextrose
4
prolotherapy beneficial
4
beneficial management
4
management temporomandibular
4
joint
4
internal derangement?
4
derangement? systematic
4

Similar Publications

Background: The aims of this review were to identify and to analyze the clinical studies that used subcutaneous injections of dextrose for treating musculoskeletal pain, in order to establish an overview.

Methods: A systematic search was carried out in scientific databases including Web of Science, Cochrane Central Register of Controlled Trials, PUBMED and other sources, up until March 2024. We included clinical studies that used subcutaneous injections of dextrose in the treatment of individuals with musculoskeletal pain associated with tendinopathies, enthesopathy, osteoarthritis, ligament sprains, muscle strains or bursitis of various locations.

View Article and Find Full Text PDF

Objectives: This study aims to compare the effectiveness of intra-articular and peri-articular dextrose prolotherapy (DPT) in patients with knee osteoarthritis (KOA) without effusion.

Patients And Methods: Between August 2018 and November 2018, a total of 51 participants including 27 cases (12 males, 15 females; mean age: 55.7±5.

View Article and Find Full Text PDF

Objective: The objective was to analyze the difference between prolotherapy and wet needling (WN) for myofascial trigger points (MTrPs) for the Visual Analog Scale (VAS), Oswestry Disability Index (ODI), Clinical Global Impression (CGI), and MTrP count.

Methods: Patients with myofascial pain for 1.5 years were included based on convenience sampling after a pilot study for sample size calculation.

View Article and Find Full Text PDF

Background: As sports have increased in popularity, the incidence of tendinopathy has also grown dramatically. Nonoperative techniques and treatments used to address these pathologies continue to evolve and improve. One such treatment, prolotherapy (PrT), has become increasingly popular and may provide patients with an alternative nonoperative treatment option.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored the effectiveness of dextrose prolotherapy compared to steroid injections in treating distal semimembranous tendinopathy, a rare cause of knee pain.
  • It included 25 patients who received either treatment and measured pain and functionality before and after the procedures using VAS and IKDC scores.
  • Results showed that while steroid injections provided quicker relief in the first week, dextrose prolotherapy produced better outcomes by the fourth week, indicating both treatments were effective for this condition.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!